GLP1 circulating levels have been shown to rapidly increase during acute ST elevation and non-ST elevation myocardial infarction (MI) and are correlated with a composite outcome of recurrence of non-fatal MI, stroke, and cardiovascular death [71]. This evidence concerns the gene GLP1R and stroke disorder.